CTRI/2021/03/031649
Completed
未知
Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types
ITC Life Sciences Technology Centre0 sites24 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ITC Life Sciences Technology Centre
- Enrollment
- 24
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarââ?¬Â¦.)
- •Subjects willing to come for regular follow up and ready to follow instructions during the study period.
Exclusion Criteria
- •For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing
- •(whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Safety of the test products to be checked.CTRI/2023/09/057621ITC Life Sciences Technology Centre24
Completed
Not Applicable
Evaluation of the safety of the product by skin sensitivity test on healthy human volunteers.CTRI/2016/12/007573ITC Life Sciences and Technology Centre24
Completed
Not Applicable
Dermatology study in healthy volunteersCTRI/2017/02/007875ITC Life Sciences and Technology Centre24
Completed
Not Applicable
24 Hrs primary irritation patch test on healthy human volunteers.MSCR/ITPT/2013-05CTRI/2013/05/003639ITC R D Centre24
Completed
Not Applicable
To evaluate the safety of products by skin sensitivity test on human male and female subjectsCTRI/2017/05/008561ITC Life Sciences Technology Centre24